The parallel involvement of both NLRP3 and AIM2 inflammasomes in maladaptive atrial remodeling underscores their potential as upstream regulators of proarrhythmic signaling cascades and supports their candidacy as novel therapeutic targets in the prevention and management of AF. This evidence concerns the gene AIM2 and atrial fibrillation.